Summer Street Starts Anthera Pharma (ANTH) at Buy, $15 Price Target
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Price: $0.00 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Summer Street's Carol Werther initiated coverage on Anthera Pharma (NASDAQ: ANTH) with a Buy rating and $15 price target Friday afternoon.
The stock is down about 2.5 percent to $6.30 at last check. Werther's new price target represents potential upside of about 138 percent from where the stock is currently trading.
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
The stock is down about 2.5 percent to $6.30 at last check. Werther's new price target represents potential upside of about 138 percent from where the stock is currently trading.
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic CFO Krishna Rao is leading early IPO meetings with investors and has not discussed valuation - CNBC
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Goldman Sachs Starts Onto Innovation Inc. (ONTO) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
